Frontlight ResearchEarly access
CompletedNo phase
Post-market Evaluation of Clinical Outcomes in China for the TECNIS Model ZMT
Key facts
- Who runs it
- Johnson & Johnson Surgical Vision, Inc.
- Where
- China7 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 102 people enrolled
- Started
- 11 Aug 2021
- Ended
- 10 Jan 2024
- Type of study
- Interventional
- Treatments tested
- Study Lens: TECNIS Multifocal Toric 1-piece lens, Model ZMT
- Record updated
- 23 May 2025
Who can take part
- Age
- 22 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Male or female at least 22 years of age
- Have a cataract in one or both eyes, with planned phacoemulsification with intraocular lens implantation
- Regular corneal astigmatism that is planned for correction with an intraocular lens in the study eye(s)
- Availability, willingness and sufficient cognitive awareness to understand the purpose of the examination procedures and comply with postoperative visits that are required by the study protocol
- Voluntary participation indicated by the study informed consent form (ICF) signed by the patient or legal guardian
Who cannot take part
- Concurrent participation or participation in any other clinical study within 30 days prior to the preoperative visit
- Ocular disease (other than cataract) that may significantly affect postoperative vision, such as visually significant keratopathy, macular lesions, diabetic retinopathy, chronic or severe uveitis, etc
- Severe or unstable systemic disease that may affect the heart, liver, kidney, lung, endocrine (including thyroid insufficiency), blood, or psychoneurological dysfunction
- Any other systemic or ocular disease that, in the opinion of the investigator, may affect the patient's eligibility for the study; -
- Planned monovision correction (one eye designated for near correction)
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This is a prospective, multicenter, single-arm, open-label clinical study of the commercially available TECNIS Multifocal Toric 1-Piece IOL. The study will enroll up to 120 subjects from up to 8 sites in China. The subjects will be followed for 12-months postoperatively.
The group in the trial
- Study LensTreatment being tested
TECNIS Multifocal Toric 1-piece lens, Model ZMT
Treatment: Study Lens: TECNIS Multifocal Toric 1-piece lens, Model ZMT
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Post-market Evaluation of Clinical Outcomes in China for the TECNIS® Multifocal Toric 1-Piece Intraocular Lens Model Series ZMT
- Record updated
- 23 May 2025